Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Immuneering Corporation (IMRX) had Cash Flow from Financial Activities of $0.18M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-13.46M |
|
-- |
|
-- |
|
$15.34M |
|
$-15.34M |
|
$1.87M |
|
$-13.46M |
|
$-13.46M |
|
$-13.46M |
|
$-13.46M |
|
$-13.46M |
|
$-13.46M |
|
$-15.34M |
|
$-15.56M |
|
64.66M |
|
64.66M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$161.41M |
|
$0.94M |
|
$53.40M |
|
$214.81M |
|
$4.97M |
|
-- |
|
$3.32M |
|
$8.29M |
|
$206.52M |
|
$199.51M |
|
$206.52M |
|
64.69M |
|
| Cash Flow Statement Financials | |
$-18.43M |
|
$-63.07M |
|
|
Cash Flow from Financial Activities |
$0.18M |
$128.65M |
|
$47.32M |
|
$-81.32M |
|
$1.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
32.45 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.51M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.52% |
|
-6.75% |
|
-6.27% |
|
-6.52% |
|
$3.19 |
|
$-0.29 |
|
$-0.29 |
|